Richard Nikolas Holttum
@Rokos Capital Management Llp
Latest period2024 - Q3ReportedManaged Assets$6.164BTotal holdings65
Assets growth rate-61.4%Assets growth rate (2-Q avg)-38.64%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Rokos Capital Management Llp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 65 positions.
Assets under management
The assets under management (AUM) of Rokos Capital Management Llp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.164B in assets, with a quarterly growth rate of -61.4% and a 2-quarter average growth rate of -38.64%. The portfolio is managed by Richard Nikolas Holttum, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CCJCameco Corp
| 0% | $53.183M 1.081M shares@ $49.18 avg price | Exited |
CCitigroup Inc
| 0% | $46.553M 733,422 shares@ $63.48 avg price | Exited |
LOWLowes Cos Inc
| 0% | $37.382M 169,682 shares@ $220.31 avg price | Exited |
INTCIntel Corp
| 0% | $34.999M 1.131M shares@ $30.94 avg price | Exited |
LRCXLam Research Corp
| 0% | $29.138M 27,394 shares@ $1063.68 avg price | Exited |
AMATApplied Matls Inc
| 0% | $28.576M 121,140 shares@ $235.9 avg price | Exited |
BKNGBooking Holdings Inc
| 0% | $25.748M 6,506 shares@ $3957.64 avg price | Exited |
NTLAIntellia Therapeutics Inc
| 0% | $25.511M 1.141M shares@ $22.36 avg price | Exited |
ARWRArrowhead Pharmaceuticals In
| 0% | $24.411M 939,984 shares@ $25.97 avg price | Exited |
UECUranium Energy Corp
| 0% | $24.037M 4M shares@ $6.01 avg price | Exited |